Cargando…
Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome
This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Correlations of baseline clinical trial data (molecular measures—FMR1 mRNA, CYFIP1 mRNA, MMP9 and FMRP protein expression levels, nonverbal IQ, body m...
Autores principales: | Aishworiya, Ramkumar, Chi, Mei-Hung, Zafarullah, Marwa, Mendoza, Guadalupe, Ponzini, Matthew Dominic, Kim, Kyoungmi, Biag, Hazel Maridith Barlahan, Thurman, Angela John, Abbeduto, Leonard, Hessl, David, Randol, Jamie Leah, Bolduc, Francois V., Jacquemont, Sebastien, Lippé, Sarah, Hagerman, Paul, Hagerman, Randi, Schneider, Andrea, Tassone, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377864/ https://www.ncbi.nlm.nih.gov/pubmed/37508583 http://dx.doi.org/10.3390/cells12141920 |
Ejemplares similares
-
EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome
por: Proteau-Lemieux, Mélodie, et al.
Publicado: (2021) -
Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome
por: Proteau-Lemieux, Mélodie, et al.
Publicado: (2022) -
Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment
por: Rajaratnam, Akash, et al.
Publicado: (2020) -
Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022) -
Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)